[Cetyltrimethylammonium bromide for fluorescence enhancement of anhydrotetracycline hydrochloride and iso-tetracycline]. 2002

Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
Department of Pharmacy, Medical University of Hebei, Shijiazhuang 050017, China.

Fluorescence enhancement of anhydrotetracycline hydrochloride and iso-tetracycline has been described. The fluorescence intensities of anhydrotetracycline hydrochloride and iso-tetracycline with cetyltrimethylammonium bromide (CTMAB) enhanced by micellar solution have been examined. It is found that fluorescence enhancement of anhydrotetracycline hydrochloride and iso-tetracycline depends on the concentration of CTMAB and pH of the solution. It can be used to develop sensitive methods for the determination of tetracycline hydrochloride and its decomposition product.

UI MeSH Term Description Entries
D002593 Cetrimonium Compounds Cetyltrimethylammonium compounds that have cationic detergent, antiseptic, and disinfectant activities. They are used in pharmaceuticals, foods, and cosmetics as preservatives; on skin, mucous membranes, etc., as antiseptics or cleansers, and also as emulsifiers. These compounds are toxic when used orally due to neuromuscular blockade. Cetyltrimethylammonium Compounds,Cetrimides,Compounds, Cetrimonium,Compounds, Cetyltrimethylammonium
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D000077286 Cetrimonium Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics. 1-Hexadecyltrimethylammonium Chloride,CTAB,CTAOH,Cetavlon,Cetrimide,Cetriminium,Cetrimonium Bromide,Cetrimonium Chloride,Cetrimonium Hydroxide,Cetrimonium Iodide,Cetrimonium Methosulfate,Cetrimonium Methyl Sulfate,Cetrimonium Monosulfate,Cetyltrimethylammonium Bromide,Cetyltrimethylammonium Chloride,HTAB Cpd,Hexadecyl Trimethyl Ammonium Bromide,Hexadecyl(trimethyl)azanium,Hexadecyltrimethylammonium Bromide,Hexadecyltrimethylammonium Octylsulfonate,Octylsulfonate, Hexadecyltrimethylammonium
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence
D013501 Surface-Active Agents Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. Surface Active Agent,Surface-Active Agent,Surfactant,Surfactants,Tenside,Amphiphilic Agents,Surface Active Agents,Tensides,Active Agent, Surface,Active Agents, Surface,Agent, Surface Active,Agent, Surface-Active,Agents, Amphiphilic,Agents, Surface Active,Agents, Surface-Active
D013752 Tetracycline A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis. 4-Epitetracycline,Achromycin,Achromycin V,Hostacyclin,Sustamycin,Tetrabid,Tetracycline Hydrochloride,Tetracycline Monohydrochloride,Topicycline,4 Epitetracycline
D013754 Tetracyclines Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)
D020033 Protein Isoforms Different forms of a protein that may be produced from different GENES, or from the same gene by ALTERNATIVE SPLICING. Isoform,Isoforms,Protein Isoform,Protein Splice Variant,Splice Variants, Protein,Protein Splice Variants,Isoform, Protein,Isoforms, Protein,Splice Variant, Protein,Variant, Protein Splice,Variants, Protein Splice

Related Publications

Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
February 1998, Guang pu xue yu guang pu fen xi = Guang pu,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
October 2005, Talanta,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
February 2006, Biochimie,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
November 2006, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
January 1988, Journal of pharmaceutical sciences,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
July 2010, Journal of fluorescence,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
July 2018, RSC advances,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
September 2011, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
September 2005, Journal of fluorescence,
Jian-peng Zha, and Ying Lin, and Xing-hui Yang, and Hai-ni Hou, and Tie-jun Wei, and Xing-li Chen
March 2018, Materials (Basel, Switzerland),
Copied contents to your clipboard!